Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 3
2015 2
2016 1
2019 1
2021 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Novel Human Tenascin-C Function-Blocking Camel Single Domain Nanobodies.
Dhaouadi S, Ben Abderrazek R, Loustau T, Abou-Faycal C, Ksouri A, Erne W, Murdamoothoo D, Mörgelin M, Kungl A, Jung A, Ledrappier S, Benlasfar Z, Bichet S, Chiquet-Ehrismann R, Hendaoui I, Orend G, Bouhaouala-Zahar B. Dhaouadi S, et al. Among authors: ledrappier s. Front Immunol. 2021 Mar 15;12:635166. doi: 10.3389/fimmu.2021.635166. eCollection 2021. Front Immunol. 2021. PMID: 33790905 Free PMC article.
A novel ΔNp63-dependent immune mechanism improves prognosis of HPV-related head and neck cancer.
Mourtada J, Lony C, Nicol A, De Azevedo J, Bour C, Macabre C, Roncarati P, Ledrappier S, Schultz P, Borel C, Burgy M, Wasylyk B, Mellitzer G, Herfs M, Gaiddon C, Jung AC. Mourtada J, et al. Among authors: ledrappier s. Front Immunol. 2023 Oct 25;14:1264093. doi: 10.3389/fimmu.2023.1264093. eCollection 2023. Front Immunol. 2023. PMID: 38022675 Free PMC article.
Cav1/EREG/YAP Axis in the Treatment Resistance of Cav1-Expressing Head and Neck Squamous Cell Carcinoma.
Burgy M, Jehl A, Conrad O, Foppolo S, Bruban V, Etienne-Selloum N, Jung AC, Masson M, Macabre C, Ledrappier S, Burckel H, Mura C, Noël G, Borel C, Fasquelle F, Onea MA, Chenard MP, Thiéry A, Dontenwill M, Martin S. Burgy M, et al. Among authors: ledrappier s. Cancers (Basel). 2021 Jun 18;13(12):3038. doi: 10.3390/cancers13123038. Cancers (Basel). 2021. PMID: 34207120 Free PMC article.
Tumor-Suppressive and Immunomodulating Activity of miR-30a-3p and miR-30e-3p in HNSCC Cells and Tumoroids.
Conrad O, Burgy M, Foppolo S, Jehl A, Thiéry A, Guihard S, Vauchelles R, Jung AC, Mourtada J, Macabre C, Ledrappier S, Chenard MP, Onea MA, Danic A, Dourlhes T, Thibault C, Schultz P, Dontenwill M, Martin S. Conrad O, et al. Among authors: ledrappier s. Int J Mol Sci. 2023 Jul 6;24(13):11178. doi: 10.3390/ijms241311178. Int J Mol Sci. 2023. PMID: 37446353 Free PMC article.
DDB2: a novel regulator of NF-κB and breast tumor invasion.
Ennen M, Klotz R, Touche N, Pinel S, Barbieux C, Besancenot V, Brunner E, Thiebaut D, Jung AC, Ledrappier S, Domenjoud L, Abecassis J, Plénat F, Grandemange S, Becuwe P. Ennen M, et al. Among authors: ledrappier s. Cancer Res. 2013 Aug 15;73(16):5040-52. doi: 10.1158/0008-5472.CAN-12-3655. Epub 2013 Jun 17. Cancer Res. 2013. PMID: 23774208
MiR-422a promotes loco-regional recurrence by targeting NT5E/CD73 in head and neck squamous cell carcinoma.
Bonnin N, Armandy E, Carras J, Ferrandon S, Battiston-Montagne P, Aubry M, Guihard S, Meyronet D, Foy JP, Saintigny P, Ledrappier S, Jung A, Rimokh R, Rodriguez-Lafrasse C, Poncet D. Bonnin N, et al. Among authors: ledrappier s. Oncotarget. 2016 Jul 12;7(28):44023-44038. doi: 10.18632/oncotarget.9829. Oncotarget. 2016. PMID: 27281619 Free PMC article.
11 results